Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 76 clinical trials
Breast Cancer WEight Loss Study (BWEL Study)

This randomized phase III trial studies whether weight loss in overweight and obese women may prevent breast cancer from coming back (recurrence). Previous studies have found that women who are overweight or obese when their breast cancer is found (diagnosed) have a greater risk of their breast cancer recurring, as …

cancer
cancer treatment
breast cancer, treatment
breast cancer
Northwest Hospital Center
 (3.8 away) Contact site
  • 4083 views
  • 22 Nov, 2020
  • +1576 other locations
Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

This phase III trial studies response-based chemotherapy in treating newly diagnosed acute myeloid leukemia or myelodysplastic syndrome in younger patients with Down syndrome. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by …

myeloid leukemia
leukemia
myeloproliferative disorder
etoposide
blast cells
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 153 views
  • 27 Sep, 2020
  • +133 other locations
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo

The main purpose of this study is to learn if the usual chemotherapy given before surgery (neoadjuvant therapy) for breast cancer plus the experimental drug, atezolizumab, is better than the usual chemotherapy plus a placebo. (A placebo is a drug that looks like the study drug but contains no medication.) …

mastectomy
adenocarcinoma
mammogram
atezolizumab
paclitaxel
Greater Baltimore Medical Center
 (9.3 away) Contact site
  • 1000 views
  • 29 Nov, 2020
  • +204 other locations
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

This phase III trial studies how well response and biology-based risk factor-guided therapy works in treating younger patients with non-high risk neuroblastoma. Sometimes a tumor may not need treatment until it progresses. In this case, observation may be sufficient. Measuring biomarkers in tumor cells may help plan when effective treatment …

mycn protein
iobenguane
etoposide
doxorubicin
catecholamines
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 265 views
  • 02 Dec, 2020
  • +117 other locations
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL Mixed Phenotype Acute Leukemia and B-LLy

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy without inotuzumab ozogamicin. Inotuzumab …

mercaptopurine
cns leukemia
cancer chemotherapy
testicular
lymphoblastic lymphoma
Sinai Hospital of Baltimore
 (7.8 away) Contact site
  • 42 views
  • 19 Aug, 2020
  • +97 other locations
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

The primary objective is to determine if BIIB093 improves functional outcome at Day 90 as measured by the modified Rankin Scale (mRS) when compared with placebo in participants with Large Hemispheric Infarction (LHI). The secondary objectives are to determine if BIIB093 improves overall survival at Day 90 when compared with …

glibenclamide
infarct
thrombectomy
stroke
glyburide
Research Site
 (7.7 away) Contact site
  • 213 views
  • 22 Sep, 2020
  • +209 other locations
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

This phase III trial studies how well blinatumomab works in combination with chemotherapy in treating patients with newly diagnosed, standard risk B-lymphoblastic leukemia or B-lymphoblastic lymphoma with or without Down syndrome. Monoclonal antibodies, such as blinatumomab, may induce changes in the body's immune system and may interfere with the ability …

mercaptopurine
blinatumomab
lymphoblastic lymphoma
cyclophosphamide
b-cell acute lymphoblastic leukemia
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 84 views
  • 02 Dec, 2020
  • +114 other locations
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

This randomized phase III trial compares immunotherapy drugs (nivolumab or brentuximab vedotin) when given with combination chemotherapy in treating patients with newly diagnosed stage III or IV classic Hodgkin lymphoma. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with …

hypothyroidism
positron emission tomography/computed tomography
human immunodeficiency virus
measurable disease
alopecia
Sinai Hospital of Baltimore
 (7.7 away) Contact site
  • 68 views
  • 02 Dec, 2020
  • +423 other locations
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Cisplatin-ineligible Participants With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

A global, randomized phase III study to evaluate perioperative pembrolizumab with radical cystectomy + pelvic lymph node dissection (RC+PLND) versus RC+PLND alone in cisplatin-ineligible patients with muscle-invasive bladder cancer (MIBC).

Greater Baltimore Medical Center ( Site 0014)
 (9.3 away) Contact site
  • 95 views
  • 02 Dec, 2020
  • +159 other locations
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

To assess the efficacy and safety of larazotide acetate versus placebo for the relief of persistent symptoms in adult celiac disease patients.

diarrhea
gluten
bloating
abdominal pain
serologic test
Research Site
 (4.0 away) Contact site
  • 823 views
  • 02 Dec, 2020
  • +189 other locations